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Background: Asthmatics are known to have esophageal hypomotility. Vagal hypofunction and prolonged
intra-esophageal acidification cause esophageal hypomotility. The contribution of gastroesophageal reflux (GER) and
vagal function to esophageal motility in asthmatics is unclear. We studied the relationship between esophageal
motility, GER and vagal function in a cohort of adult asthmatics.
Methods: Thirty mild, stable asthmatics (ATS criteria) and 30 healthy volunteers underwent 24-hour ambulatory
esophageal monitoring, manometry, autonomic function testing and GER symptom assessment. 27 asthmatics
underwent gastroscopy. A vagal function score calculated from 3 tests (valsalva maneuver, heart rate response to
deep breathing and to standing from supine position) was correlated with esophageal function parameters.
Results: Asthmatics (mean age 34.8 (SD 8.4), 60% female) had more frequent GERD symptoms than controls (mean
age 30.9 (SD 7.7), 50% female). 10/27 asthmatics had esophageal mucosal damage, 22 showed hypervagal
response, none had a hyperadrenergic response. 14 asthmatics had ineffective esophageal motility. Higher
GERD-score asthmatics had significantly fewer peristaltic and more simultaneous contractions than controls, and
higher esophageal acid contact times than those with lower scores. All reflux parameters were significantly higher
and acid clearance time prolonged in asthmatics than controls (p < 0.001, Mann–Whitney U test). There was no
correlation between vagal function score and esophageal function parameters.
Conclusions: A cohort of adult asthmatics was found to have peristaltic dysfunction and pathological GER, but
otherwise normal esophageal motility. The peristaltic dysfunction seems to be associated with vagal hyperreactivity
rather than vagal hypofunction.Background
Asthmatics are known to have an increased prevalence of
gastroesophageal reflux disease (GERD) symptoms,
esophageal hypomotility and abnormal acid exposure [1].
A study revealed that asthmatics had significantly lower
LES pressures [1]. In 34 non-allergic asthmatic people
who underwent esophageal manometry because of gastro-
intestinal symptoms, 23 (68%) had esophageal dysmotility
with low amplitude esophageal contractions, hypotensive
lower esophageal sphincter (LES) and diffuse esophageal* Correspondence: lakmaliamarasiri@gmail.com
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reproduction in any medium, provided the orspasm [2]. Ineffective esophageal motility (IEM) was
found to be the most common motility abnormality in
patients with GERD-associated respiratory symptoms [3].
Studies on asthmatics revealed increased frequency of
transient lower esophageal sphincter relaxations (TLESRs)
and increased acid contact times [4].
Reduced motility of the esophagus may be due to vagal
hypofunction [5]. However on the contrary asthmatics
have evidence of a hypervagal response [6]. A study on
15 asthmatics revealed that 8 had a hypervagal response
and of the 7 who had a mixed response there was a pre-
dominance of hypervagal tone [7].
Esophageal hypomotility may also be secondary to dam-
age from prolonged intra-esophageal acidification. Abnor-
mal reflux is prominent in asthmatics. An endoscopical Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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dence of esophagitis or Barrett esophagus [8]. A retro-
spective analysis of 24 hour pH monitoring done in 199
asthmatics showed that 82% had symptomatic GER, of
which 72% were reflux positive [9]. Sontag et al. reported
that 82% of 104 adult asthmatics had abnormal amounts
of acid reflux, more frequent reflux episodes, higher
esophageal contact times and longer esophageal acid
clearance times (p < 0.0001 for all parameters tested) irre-
spective of presence of symptoms [1]. In 105 consecutive
asthmatics, the prevalence of GER was 32% on prolonged
ambulatory pH monitoring [10].
Hence, whether esophageal hypomotility in asthmatics is
due to vagal hypofunction or secondary to damage from
gastro-esophageal reflux (GER) is unclear. The aim of this
study was to study the relationship between esophageal
motility, GER and vagal function in adult asthmatics.
Methods
Thirty consecutive asthmatics who met American Thoracic
Society (ATS) guidelines for the definition of asthma (12%
improvement and 200 mL increase in FEV1 following bron-
chodilator administration) [11] were recruited from med-
ical clinics, irrespective of their GERD symptom status,
asthma severity or asthma medication use. Controls were
either clinic attendees, those accompanying them or hos-
pital staff who denied having respiratory symptoms, asthma
or other respiratory illness. Being a smoker, alcoholic, dia-
betic, presence of known esophageal disease or a history of
previous upper gastro-intestinal surgery served as add-
itional exclusion criteria for both asthmatics and controls.
This study was approved by the Ethics and Scientific
Review Committee of the Faculty of Medicine of the
University of Kelaniya, Ragama, Sri Lanka. All proce-
dures were conducted following written informed con-
sent and conform to the Declaration of Helsinki.
All subjects underwent autonomic and esophageal
function tests, a GERD symptom assessment and the
asthmatics underwent upper gastro-intestinal endoscopy.
Vagal autonomic function was assessed by
a) valsalva maneuver produced by sustaining a forced
expiration through a mouthpiece connected to a
manometer (40 mmHg) lasting 15 s, following a deep
inspiration
b)heart rate variation with quiet and deep breathing
(six breaths per minute)
c) heart rate response to standing from supine position.
Sympathetic function was assessed by:
d) blood pressure response to standing from supine
position.For correlation with gastro-intestinal function para-
meters, a vagal function score was calculated from the
results of the three tests. For each test, the result of each
individual was ranked on a scale from 1 to 100. The
three values were added and averaged for an individual.
GERD symptom assessment
Both asthmatics and controls were screened by a previ-
ously validated GERD screening score assessing frequency
and severity of seven common upper gastrointestinal
symptoms on a 5-point Likert scale. Symptoms included
were 1) heartburn 2) regurgitation 3) upper abdominal or
chest pain 4) abdominal distension 5) dysphagia 6) cough
and 7) belching. A GERD score was calculated as the sum
of the products of frequency and severity of each symp-
tom. A cut of score of ≥ 12.5 was considered as a positive
GERD score [12].
Upper gastrointestinal (UGI) endoscopy
UGI endoscopy was performed in 27 asthmatics that con-
sented. The procedure was performed by 2 trained physi-
cians using a fibreoptic endoscope (Olympus, CLV-U20)
and findings graded according to modified Savary-Miller
criteria [13]. Endoscopy was not performed in controls.
Tests of esophageal function
Esophageal motility was assessed by the stationary pull-
through method, using a water perfused system (Synetics
PC Polygraf system, Stolkholm, Sweden) according to
standard methodology. We had no provision to measure
LES pressure using a Sleeve mechanism.
Antacids were discontinued 24 hours before, drugs
that could affect gastrointestinal motility at least 48 hours
before and any anti-secretory drugs one week prior to
the study. All asthma medication was withdrawn for
48 hours, allowing inhaled beta-2 agonists on an as
needed basis. No food or drink was allowed for at least
6 hours prior to intubation to reduce risk of aspiration
during intubation [14].
Nasal intubation was done with application of local
anesthetic gel (lignocaine) and a lubricant gel. LES,
esophageal body and UES pressures were studied accord-
ing to standard pull-through method in response to 5 mL
water boluses. Overall parameters were summated for
each subject to classify them manometrically [15].
24-hour ambulatory esophageal pH monitoring was
performed on all subjects using a dual sensor mono-
crystalline antimony catheter (Synetics Medical AB,
Stolkholm, Sweden), according to standard method-
ology [16]. The distal sensor of the pH catheter was
positioned 5 cm above the superior border of the man-
ometrically determined LES and the proximal sensor
was 15 cm above the distal sensor. Reflux was assessed
based on the score derived from DeMeester and
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ation of the longest reflux episode, number of reflux
episodes lasting longer than 5 minutes, total percent-
age of time pH < 4, time pH < 4 during upright expos-
ure, time pH < 4 during supine exposure and the
DeMeester score. The acid contact time was defined as
the percentage of the total 24 hour period with pH < 4.
Meal times, supine periods, and GERD symptoms dur-
ing the recording period were noted for each subject
[17].Statistical analysis of results
Non parametric tests (Wilcoxon Rank Sum test for
paired data and Mann Whitney U test for unpaired data)
were used to compare the data between the asthmatics
and controls. Data was expressed as median (range)
using 5th and 95th centile values unless specified other-
wise. The upper 95th centile of normal values was used
to classify abnormal pH exposure. Categorical variables
were compared using the χ2 and Fisher Exact tests.
Spearman rank correlation was used to study the associ-
ation between vagal function and esophageal motility
and 24 hour ambulatory pH monitoring variables. A
P value of ≤ 0.05 was considered significant. All stat-
istical analysis was performed using SPSS version 10.0
for Windows software (SPSS Inc., Chicago, IL, USA).Results
Demographics
The 30 asthmatics and 30 controls that completed the
study were found to be comparable in terms of age, gen-
der and body mass index. The asthmatics had a higher
frequency and severity of GERD symptoms (Table 1).
All asthmatics had only occasional asthma symptoms
over the preceding two weeks before the study. They
continued their current medication (Table 2). On GERD
symptom assessment, all controls had negative GERD
symptom scores. Of the asthmatics, 20 had positive
GERD symptom scores and 10 had negative GERD
symptom scores. The demographic details of the asth-
matic population are given in Table 2. The two groupsTable 1 Baseline characteristics of asthmatics and
controls
Controls Asthmatics P value
Age, yrs 30.9 ± 7.7 34.8 ± 8.4 0.075
Gender, (M:F) 15:15 12:18 0.604
BMI, (kg/m2) 21.8 ± 3.6 21.3 ± 4.4 0.647
GERD symptom score
(frequency x severity)
7.6 ± 0.8 32.0 ± 21.1 0.000*
* Student t-test BMI = Body Mass Index GERD = gastro-esophageal reflux
disease.
All values mean ± SD unless specified otherwise.differed significantly only in the mean GERD symptoms
scores and presence of esophagitis.
Twenty seven asthmatics consented to UGI endos-
copy. Of 20 asthmatics with positive GERD symptom
scores, 12 had no evidence of mucosal damage, 7 had
grade I esophagitis and one subject had grade III
esophagitis. Of 7 asthmatics with negative GERD symp-
tom scores, 5 had no evidence of mucosal damage and 2
subjects had grade I esophagitis.
The test values of 29 of the controls were within the nor-
mal ranges defined for tests of cardiovascular autonomic
function [18]. One demonstrated a hypervagal response.
Of the asthmatics twenty two (69%) demonstrated a hyper-
vagal response. None showed a hyperadrenergic response.
Stationary esophageal manometry study
During the stationary esophageal manometry study, the
results of 1 asthmatic and 10 control subjects was
excluded from analysis, as equipment failure prevented
the manometry study from being performed in these sub-
jects. In those subjects, the position of the lower esopha-
geal sphincter was located by the pH step-up method.
According to the current classification of esophageal
motility patterns [15], 16 controls had evidence of nor-
mal esophageal motility while 4 showed ineffective
esophageal motility. Of the asthmatics, 10 had a normal
motility pattern, 2 had evidence of a hypercontracting
esophagus and 17 of a hypocontracting esophagus (of
which 14 showed IEM, 2 showed a hypotensive LES and
1 had an incompletely relaxing LES).
There was no difference of LES mean end-expiratory
values and LES relaxation between asthmatics and con-
trols. There was no difference in the LES length or in
UES parameters between the two groups. There was no
significant difference in the mean peristaltic amplitude
and duration for each group at each position (5 cm,
10 cm and 15 cm above the LES) in the esophagus and
the mean peristaltic wave velocity between the two
groups (Table 3). When the median percentage of each
type of contraction (peristaltic, simultaneous and low
amplitude) was compared between the two groups, per-
centage of peristaltic contractions was significantly lower
in the 29 asthmatics compared to the 16 controls who
had normal esophageal manometry (80% (10-100%) ver-
sus (100% (90–100); P = 0.044, Mann Whitney U test).
When the data of the 4 controls with IEM was consid-
ered, the difference remained, though not significant.
Asthmatics with positive GERD symptom scores had a
significantly lower percentage of peristaltic contractions
and a significantly higher percentage of simultaneous
contractions than the controls (Table 3). There was no
significant difference in any parameter between controls
and asthmatics with negative GERD symptom scores
(P > 0.05 for all parameters; Mann Whitney U Test).
Table 2 Demographic details of asthmatics
Asthmatics with negative GERD
symptom scores (n = 10)
Asthmatics with positive GERD
symptom scores (n = 20)
All asthmatics
(n = 30)
Age, yrs mean ± SD 35.4 ± 9.6 34.5 ± 8.0 34.8 ± 8.4
Gender, (M:F) 2:8 9:11 12:18
BMI, (kg/m2), mean ± SD 20.3 ± 2.4 21.9 ± 5.1 21.3 ± 4.4
GERD symptom score, mean ± SD* 10.0 ± 1.6 43.1 ± 17.0 32.0 ± 21.1
Upper GI endoscopy status, no of subjects **
Normal 5 12 17
Esophagitis, grade 1 2 7 9
Esophagitis, grade 2 - - -
Esophagitis, grade 3 - 1 1
Severity of asthma, no of subjects (%)
Mild intermittent 10 (100) 16 (80) 26 (87)
Mild persistent - 4 (20) 4 (13)
On oral drugs, no of subjects (%)
Oral salbutamol 6 (60) 11 (55) 17 (57)
Inhaled salbutamol 4 (40) 5 (25) 9 (30)
Oral theophylline 5 (50) 6 (30) 11 (37)
Oral steroids 4 (40) 7 (35) 11 (37)
Inhaled steroids 4 (40) 10 (50) 14 (47)
Spirometry results, mean ± SD
FVC 3.2 ± 0.4 3.2 ± 0.6 3.2 ± 0.5
FEV1 2.7 ± 0.5 2.7± 0.4 2.7 ± 0.4
FEV1/FVC % 85.2 ± 9.5 82.9 ± 11.0 83.7 ± 10.4
* p < 0.001; Student t test ** p < 0.05; Fisher exact test.
All other parameters did not significantly differ between the two groups.
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All reflux parameters were found to be significantly
higher in asthmatics compared to controls (Table 4).
Asthmatics with positive GERD symptom scores showed
higher total and upright esophageal acid contact times in
the proximal esophagus compared to those with negative
scores. Abnormal proximal acid reflux was documented
in 20 of 30 asthmatics (66.7%) and abnormal distal reflux









Controls (n = 16) 74.6 ± 6.3 74.6 ± 7.6 74.9 ± 8.8 74.2 ± 8.9 10
Asthmatics with-GERD
symptom scores (n = 9)
68.9 ± 7.9 62.7 ± 9.0 63.3 ± 7.0 80.7 ± 3.9 10
Asthmatics with + GERD
symptom scores (n = 20)
74.6 ± 7.0 57.3 ± 5.6 75.5 ± 8.0 91.2 ± 11.6 75
All asthmatics (n = 29) 72.8 ± 5.3 59.6 ± 4.0 71.7 ± 6.0 87.9 ± 9.0 80
GERD = gastro-esophageal reflux disease; Values are mean ± SE unless otherwise sp
† p < 0.05, Mann Whitney U test.Asthmatics had significantly prolonged proximal and
distal acid clearance time (total time pH < 4 divided by the
no of reflux episodes) compared to controls (p < 0.001,
Mann–Whitney U test). The median acid clearance time
values in asthmatics with positive GERD symptom scores
was higher than those who had negative GERD symptom
scores, but the difference was not significant. The GERD
score showed significant negative correlation with LES
length and significant positive correlation with thehageal body in asthmatics and controls








0 (90–100) 0 0 (0–10) 3.7 ± 0.6 2.5 ± 0.2
0 (30–100) 0 0 (0–70) 1.8 ± 0.3 6.6 ± 3.9
(10–100) 0 (0–49) 0 (0–70) 4.0 ± 0.8 3.3 ± 0.3
(15–100)† 0 (0–55) 0 (0–80) 3.3 ± 0.6 4.3 ± 1.2
ecified; * Median (range as 5th and 95th centiles);
Table 4 Acid exposure values among asthmatics and controls
Controls Asthmatics with (−) GERD
symptom score
Asthmatics with (+) GERD
symptom score
All asthmatics*
Proximal sensor (n = 16) (n = 10) (n = 20) (n = 30)
Total time pH < 4 (%) 0.07 (0–0.4) 2.0 (0.2-10.6) 2.3 (0.03-50.9) 2.1 (0.04-29.7)
Upright time pH < 4 (%) 0.02 (0–0.4) 1.3 (0–24.0) 3.3 (0–66.3) 1.3 (0–44.0)
Supine time pH < 4 (%) 0.12 (0–0.5) 3.2 (0–17.8) 0.2 (0–34.6) 0.4 (0–25.9)
Total no. of reflux episodes 6.0 (0–25.0) 52.0 (3.0-193.0) 55.5 (0.2-233.0) 52 (1.6-233.0)
No. of episodes ≥ 5 min 0 (0–1.0) 2 (0–128.3) 3.5 (0–122.5) 3 (0–128.3)
Longest episode (min) 0.9 (0–7.8) 10.0 (1.0-155.4) 37.8 (0.06-205.7) 25.8 (0.07-189.4)
DeMeester score 0.95 (0.2-4.8) 23.4 (4.4-64.0) 22.3 (0.2-152.7) 23.4 (0.4-106.0)
Distal sensor (n = 26)
Total time pH < 4 (%) 0.4 (0.08-1.5) 6.3 (1.0-14.7) 7.9 (0.3-35.7) 7.4 (0.5-19.8)
Upright time pH < 4 (%) 0.2 (0–3.0) 6.5 (0–28.8) 4.0 (0–53.9) 4.9 (0.08-30.2)
Supine time pH < 4 (%) 0.4 (0.07-2.8) 4.6 (0.4-13.4) 2.7 (0.01-25.5) 3.0 (0.4-15.6)
Total no. of reflux episodes 18.0 (2.7-94.2) 33.5 (9.0-162.0) 65.5 (10.0-180.0) 43.5 (10.3-162)
No. of episodes ≥ 5 min 0 (0–2) 2.0 (1.0-9.0) 6.5 (0–15.7) 3.5 (1–9.4)
Longest episode (min) 1.9 (0.5-20.6) 12.8 (7.8-104.5) 27.5 (0.5-126.0) 20.1 (1.4-104.5)
DeMeester score 3.35 (0.7-11.5) 17.9 (5.4-55.6) 33.7 (2.2-131.0) 23.1 (5.4-61.2)
Values are median (range as 5th and 95th centiles).
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proximal and distal positions and the duration of the long-
est reflux at the proximal sensor. The score also showed
an expected negative correlation with amplitude of con-
tractions and UES pressure and expected positive correla-
tions with all the other proximal and distal reflux
parameters, though not significant.Discussion
Asthmatics are known to have a high prevalence of GER
and GER is known to trigger asthma [19]. Initial epi-
sodes of reflux may induce acute esophageal injury
resulting in lowered LES pressure, delayed acid clearing
and more reflux [20]. As reflux continues, aspiration
may follow causing the first asthmatic episode.
Sensitization of the pulmonary tree may cause the air-
ways to become reactive to other stimuli resulting in
bronchospasm through a vagal mechanism [1].
Factors that may promote GER in asthma include,
physical characteristics of the individuals (age, gender
and body mass index), disruption of LES mechanism
(related to asthma severity and presence of hiatal hernia),
reduced LES pressure and increased esophageal acid con-
tact times (effect of asthma medication) [21] and auto-
nomic dysregulation [7]. Increasing age [22], the male
sex [23] and increased body mass index [24] predispose
towards increased GER. The population of asthmatics
and controls in the present study was comparable in
these characteristics; hence any confounding influence of
these factors would have been minimal.In this study, the asthmatics demonstrated a high use of
oral medication (Table 1). Regression analysis revealed
that the use of asthma medication (overall and oral versus
inhaled) did not seem to influence the difference in
oesophageal function parameters between asthmatics and
controls.
The asthmatics were recruited from medical clinics. In
their history on recruitment it was clarified that these
were patients who had been having asthma for a consid-
erable period of time and even childhood asthma. They
did not have long term symptoms of gastro-oesophageal
reflux disease. The classification regarding presence or
absence of GERD symptoms was based on a question-
naire with a recall period of 4 weeks. However, there is
no possibility of excluding ‘silent gastro-oesphageal re-
flux’. So there is a possibility that some may have had
GERD as their primary pathology.
The present study revealed that 10 of 27 asthmatics
(37%) had evidence of esophagitis. The average preva-
lence of erosive esophagitis in asthmatics reported in a
recent systematic review was also 37% [19]. Most studies
report that the severity of esophagitis has a positive cor-
relation with the degree of asthma severity [8,25,26].
The fact that our population of asthmatics had less se-
vere asthma may have contributed to the low prevalence
of esophagitis in them. We did not perform UGI endos-
copy on the controls. We considered it unethical to do
so, when they scored negative for GERD on a previously
validated GERD screening questionnaire [12] which was
shown to have good correlation with reflux status as
determined by 24 hour pH monitoring.
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acid exposure of the distal esophagus and 20 (66.7%) of
the proximal esophagus. Individual pH monitoring para-
meters were significantly higher (both proximal and dis-
tal) in asthmatics compared to controls. The acid
exposure values were higher in asthmatics that scored
positive for GERD symptoms compared to those with
lower values. Other studies in similar settings to ours
(cross-sectional surveys in secondary care units sampling
consecutive asthmatics) have reported high acid expos-
ure values ranging from 14.8-81.8%. A systematic review
of these studies revealed a pooled sample-size weighted
average prevalence of 50.9% [19]. Of the studies describ-
ing dual-sensor pH monitoring, abnormally high prox-
imal acid exposure was reported as 46% in 56 asthmatics
[27] and abnormally high distal acid exposure was
reported in 78% of 54 asthmatics [28]. Gustafsson et al.
reported pathological reflux in 50% of asthmatic children
in the proximal esophagus and in 16% in the proximal
esophagus [29]. DeMeester et al. reported that 50% of
patients with chronic respiratory symptoms with prox-
imal reflux had esophageal dysmotility [30].
The anti-reflux barriers that protect against reflux are
the gastresophageal junction (LES function), esophageal
body motor function and acid clearance and the UES
[31].
Asthmatics have been shown to have lower LES pres-
sures [1,32]. The present study showed that only 2 asth-
matics had LES hypotension and that the LES pressure
value did not differ between asthmatics (with or without
reflux) and controls significantly. A previous study
reported similar findings [33]. Two studies involving
patients with suspected laryngeal reflux have also revealed
the same results [34,35]. Stationary pull-through method
was employed according to the available facilities in our
unit. The gold standard for measurement of LES pressure
is use of a Dent Sleeve [36,37]. However this technique
was not available to us at the time of the study. Hence in-
terpretation of data regarding LES pressure is done with
caution. Failure to demonstrate a relationship between
LES pressure and LES events with the severity of GERD
could be attributed to the inferior technique employed.
This is a severe limitation of the study. With proper and
better techniques, a repeated study would enable a more
thorough and accurate assessment of actual LES events
during reflux episodes in asthmatics.
Another disadvantage in our methodology and hence a
major limitation in our study is that stationary pull-
through manometry does not record LES pressure con-
tinuously, hence fails to capture sphincter relaxations
and intermittent reflux episodes.
The UES parameters in our study were similar in asth-
matics and controls. Ours was not an ideal setup to
measure UES pressure. This is a major limitation in ourstudy, hence data on UES measurement is not discussed
here.
Esophageal peristalsis [38] and amplitude of peristaltic
contractions [39] play a major role in esophageal acid
clearance following GER episodes. Esophageal motility
disturbances could contribute to or result from patho-
logical GER. We compared esophageal motility para-
meters between asthmatics and controls, between
asthmatics who had positive GERD symptom scores with
those with negative scores and each of these groups sep-
arately with controls. When individual esophageal motil-
ity parameters were compared [40], asthmatics differed
from controls only by a significantly lower proportion of
peristaltic waves. Asthmatics with higher GERD symp-
tom scores had lower peristaltic activity.
In the present study the asthmatics demonstrated low
peristaltic activity but otherwise normal esophageal
manometry. Hence, it is likely that these asthmatics do
not have an intrinsic esophageal motility abnormality
leading to GER. Therefore, rather than vagal hypofunc-
tion contributing to the esophageal dysmotility, as is cur-
rently accepted, it may be vagal-hyperreactivity that
leads to esophageal dysmotility. Our results lead us to
speculate whether this is due to vagal hyperreactivity-
induced increased secretion. Whether the reduced
esophageal motility is secondary to increased GER due
to vagal hyperreactivity and resulting reduced acid clear-
ance warrants further study.
When esophageal parameters were grouped according
to motility patterns, asthmatics were found to have a
higher frequency of abnormal motility patterns. The most
common motility pattern among asthmatics was ineffect-
ive esophageal motility (IEM) 44.4% of 29 asthmatics).
IEM has previously been described as the commonest mo-
tility pattern in subjects with reflux-associated respiratory
symptoms [3]. Campo et al. described esophageal dysmo-
tility in 68% of asthmatics with reflux symptoms [2].
Abnormal esophageal motility has been described in
patients with chronic cough [41]. Patti et al. found non-
specific esophageal motility abnormalities in patients with
pulmonary aspiration and GERD [42]. A study from
Taiwan reported that out of 56 clinically stable asthmatics,
23 had IEM and 12 had non-specific motility disorder
[43]. There are however some studies contradicting this
relationship, and these have reported that IEM has no as-
sociation with GERD or extra-esophageal GERD [44,45].
IEM is associated with increased acid clearance times
in the distal esophagus [46]. Esophageal acid clearance
time is the amount of time necessary to return the
esophagus to a neutral pH following an acidic reflux
event [34]. It is one of the important mechanisms that
prevent GERD [29]. Initially there is rapid clearance of
the refluxate by gravity and primary or secondary peri-
stalsis, followed by slow neutralization of the acid by the
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constant among subjects [34]; hence acid clearance is
considered a good measure of esophageal function. Peri-
staltic dysfunction could delay esophageal acid clearance.
This would keep acid in the esophagus for a longer dur-
ation and promote acid reaching a higher level [45,47].
Vagal hypofunction is known to contribute to esopha-
geal hypomotility [5]. Studies have reported that in
GERD patients, there is no correlation between auto-
nomic function state and esophageal motility or esopha-
geal acid exposure [5]. In the present study, asthmatics
did not have evidence of vagal hypofunction, but rather
showed a vagal hyper-reactivity. We could not demon-
strate correlation between a derived vagal function score
and esophageal motility, increased acid exposure or the
presence of esophagitis.
The current Montreal consensus on GERD states that
though frequency and severity of symptoms have been
shown to have a moderate correlation with severity of
endoscopic findings in several studies, symptoms cannot
accurately predict endoscopic findings of an individual
patient [48]. In this context there is difficulty in diagnos-
ing pathological GER by either symptoms or investiga-
tion alone. The present study too failed to demonstrate
an association of reflux status with upper GI endoscopy
findings, symptom severity or esophageal motility pattern
among asthmatics.
From the present study findings it seems that hyper-
vagal response and prolonged esophageal acid exposure
are the more likely reasons for the esophageal peristaltic
dysfunction. Increased vagal stimulation increases rate
and amount of acid secretion and could therefore aug-
ment the damaging effects of GER in these subjects [49].
Acid also inhibits the vagal low threshold mechano-
sensors in the esophagus that are responsible for the
reflex regulation of esophageal motor functions. This
inhibition could result in reduced esophageal clearance
or reduced LOS function, thereby favouring further
GER [50].
Conclusions
In conclusion, the present study showed that asthmatics
with mild, clinically stable asthma have peristaltic dys-
function and increased GER, but otherwise normal
esophageal motility parameters compared to healthy con-
trols. Those with more severe GERD symptoms had
more peristaltic dysfunction. The asthmatics also showed
a vagal hyper-reactivity rather than a vagal hypofunction.
Whether the peristaltic dysfunction is secondary to
increased GER resulting from the vagal-hyperreactivity
warrants further study.
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